DINOPROSTONE for Cervical dilatation: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5 adverse event reports in the FDA FAERS database where DINOPROSTONE was used for Cervical dilatation.
Most Reported Side Effects for DINOPROSTONE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Foetal exposure during pregnancy | 67 | 9.3% | 3 | 23 |
| Uterine hyperstimulation | 65 | 9.0% | 1 | 13 |
| Off label use | 52 | 7.2% | 1 | 25 |
| Premature separation of placenta | 48 | 6.6% | 0 | 7 |
| Maternal exposure during pregnancy | 46 | 6.4% | 0 | 25 |
| Postpartum haemorrhage | 40 | 5.5% | 7 | 16 |
| Premature baby | 40 | 5.5% | 1 | 16 |
| Drug ineffective | 36 | 5.0% | 0 | 5 |
| Foetal heart rate deceleration abnormality | 36 | 5.0% | 1 | 8 |
| Premature delivery | 33 | 4.6% | 1 | 14 |
| Exposure during pregnancy | 32 | 4.4% | 1 | 9 |
| Uterine rupture | 32 | 4.4% | 1 | 11 |
| Haemoglobin decreased | 31 | 4.3% | 0 | 14 |
| Uterine hypertonus | 31 | 4.3% | 0 | 10 |
| Foetal exposure during delivery | 30 | 4.2% | 3 | 3 |
Other Indications for DINOPROSTONE
Labour induction (286)
Induction of cervix ripening (182)
Product used for unknown indication (154)
Induced labour (23)
Foetal exposure during pregnancy (8)
Delivery (5)